Alzamend Neuro announces 1-for-9 reverse stock split effective May 12 to maintain Nasdaq listing

Alzamend Neuro, Inc.

Shares outstanding reduce from ~7,208,591 to ~800,954 at 1-for-9 ratio.
Split effective May 12, 2025; trading symbol remains ALZN with new CUSIP 02262M605.
Reverse split aimed at complying with Nasdaq $1.00 minimum bid price requirement.
No fractional shares issued; holders of fractional shares will receive cash payment.
Par value unchanged at $0.0001 per share; all options/warrants proportionally adjusted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.